 |
Webinar-RecordedWebinar-Biologics Analytical Methods-Trends and Strategies to Accelerate Biologics Development |
Over the past several years, the pharmaceutical market has been investing more resources into expanding biologic pipelines, creating a need for better and faster analytical tools to accelerate product development. This webinar will both summarize the current biologics analytical landscape and discuss identifying and overcoming current challenges.
Learn more about:
An overview of the current bioanalytical landscape, the challenges faced, and the strategies to overcome the challenges
How a stepwise approach for biologics analytical testing can be used to reduce risks and challenges present in biologics development
The criteria requested by regulatory authorities for a validated method
Why Catalent?
Catalyst + Talent
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of more than 7,000 products to over 1,000 customers annually. Catalent’s expert workforce exceeds 17,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
